Starts in:

By Matt Harrington, BCBA · Behaviorist Book Club · Research-backed answers for behavior analysts

Telehealth vs. In-Person Discrete Trial Teaching: Frequently Asked Questions

Questions Covered
  1. What does the research say about comparing telehealth DTT to in-person DTT for children with autism?
  2. Which learners are likely to be good candidates for telehealth DTT?
  3. How do I maintain treatment integrity when delivering DTT via telehealth?
  4. What are the limitations of providing DTT via telehealth?
  5. How should I document the clinical rationale for choosing telehealth DTT over in-person services?
  6. Can reinforcer efficacy differ in telehealth versus in-person DTT sessions?
  7. What modifications to error correction procedures are needed in telehealth DTT?
  8. What does BACB ethics say about offering telehealth as the primary service modality?
  9. How should supervisors train new therapists specifically for telehealth DTT delivery?
  10. How does service modality interact with generalization programming in DTT?

1. What does the research say about comparing telehealth DTT to in-person DTT for children with autism?

Research directly comparing telehealth and in-person DTT is still emerging, but preliminary studies including Dr. Leaf's work suggest that outcomes can be comparable for certain learners and skill targets. The key finding is that telehealth DTT is not universally inferior — but equivalence is not guaranteed and depends heavily on learner characteristics, caregiver involvement, and implementation fidelity. Practitioners should treat these studies as a foundation for clinical decision-making rather than as blanket permission or blanket prohibition on telehealth DTT delivery.

2. Which learners are likely to be good candidates for telehealth DTT?

Learners who respond well to screen-based instruction, have established instruction-following skills, do not require physical prompting, and have caregivers available and trained to assist during sessions tend to be stronger candidates for telehealth DTT. Learners with limited screen tolerance, those in early stages of attending skill development, or those who require intensive gestural or physical prompts are typically better served by in-person delivery. A learner-specific pre-assessment should guide this decision in every case, and ongoing data review should confirm whether the chosen modality is producing acquisition.

3. How do I maintain treatment integrity when delivering DTT via telehealth?

Treatment integrity in telehealth DTT requires explicit protocols for antecedent delivery, consequent timing, inter-trial intervals, and error correction. Practitioners should use structured checklists and record sessions when possible for integrity review. Caregiver training is critical because a proximate caregiver often needs to provide physical prompts or manage materials. BCBAs should conduct regular direct observation sessions via live video to score implementation fidelity rather than relying solely on session notes or caregiver report. Deviations from protocol should be addressed with targeted staff or caregiver training.

4. What are the limitations of providing DTT via telehealth?

Telehealth DTT has several structural limitations. Physical prompting is not possible without a trained caregiver or therapist on-site. Technology latency can disrupt consequence timing, which is critical for learning. Visual and auditory stimuli must be presented through a screen, which alters stimulus conditions compared to tabletop or naturalistic in-person delivery. Learner attention may be harder to manage without physical proximity. These limitations do not preclude telehealth DTT but they require adaptation and should be factored into program planning and monitoring.

5. How should I document the clinical rationale for choosing telehealth DTT over in-person services?

Documentation should address several domains: the learner's profile and why they are a suitable candidate, the environmental conditions supporting telehealth delivery, caregiver training status, the specific skills targeted and why those targets are appropriate for virtual delivery, and the data-monitoring plan in place to assess outcomes. If telehealth is being used primarily due to access constraints rather than clinical preference, that should be noted along with a plan to reassess if outcomes are insufficient. This documentation supports compliance with BACB Code 2.01 and provides a defensible record of clinical reasoning.

6. Can reinforcer efficacy differ in telehealth versus in-person DTT sessions?

Yes. Reinforcer efficacy can shift across contexts, and the social-motivational conditions in telehealth sessions differ meaningfully from in-person interactions. The establishing operation for social praise delivered via screen may be weaker than the same consequence delivered in-person, particularly for young learners who have limited screen exposure. Practitioners should conduct or adapt preference assessments within the telehealth context and should not assume that reinforcers identified in-person will function equivalently online. Monitoring response rate and accuracy across modalities can reveal reinforcer-related differences.

7. What modifications to error correction procedures are needed in telehealth DTT?

Standard error correction in DTT often involves a transfer trial using a most-to-least prompt hierarchy, which may require physical prompting. In telehealth, practitioners need to adapt error correction to rely on gestural prompts delivered visually or caregiver-mediated physical prompts. Verbal models are also commonly used. The transfer trial sequence should be maintained as closely to the standard format as possible, but practitioners should evaluate whether the adapted procedure produces the same error-reduction effects. Data on error patterns across sessions should be reviewed to determine if corrections are effectively reducing repeated errors.

8. What does BACB ethics say about offering telehealth as the primary service modality?

BACB Code 2.01 requires practitioners to use effective, evidence-based interventions. Offering telehealth as a primary modality requires a clinical basis — not just a logistical one. Practitioners must monitor outcomes and be prepared to recommend in-person services if data indicate that telehealth is insufficient. Code 2.03 requires informed consent, meaning caregivers and adult clients should understand the nature of telehealth delivery and what evidence supports it. Where telehealth is the only available option due to access constraints, practitioners should document this context and maintain rigorous outcome monitoring.

9. How should supervisors train new therapists specifically for telehealth DTT delivery?

Supervision for telehealth DTT should include competency-based training modules specific to the virtual format. Trainees should demonstrate proficiency in delivering clear antecedents via screen, timing consequences appropriately despite potential latency, and conducting or directing error correction with caregiver assistance. Supervisors should observe trainees via live video before approving them to deliver services independently via telehealth. Role-play practice with simulated technology disruptions is also valuable. Training should be documented with the same rigor as in-person competency checks under BACB supervision standards.

10. How does service modality interact with generalization programming in DTT?

Generalization programming requires exposure to varied instructors, settings, and stimulus conditions. Telehealth DTT can contribute to generalization by adding a novel setting (the home environment on-screen) and a distinct instructor context, but it also reduces stimulus variability in some respects — particularly if all telehealth sessions occur in the same physical location with the same caregiver present. Practitioners should intentionally build generalization conditions into telehealth programming, including varying the physical backdrop, rotating caregivers who assist on-screen, and planning for periodic in-person probe sessions to assess whether skills acquired via telehealth transfer to other contexts.

FREE CEUs

Get CEUs on This Topic — Free

The ABA Clubhouse has 60+ on-demand CEUs including ethics, supervision, and clinical topics like this one. Plus a new live CEU every Wednesday.

60+ on-demand CEUs (ethics, supervision, general)
New live CEU every Wednesday
Community of 500+ BCBAs
100% free to join
Join The ABA Clubhouse — Free →

Earn CEU Credit on This Topic

Ready to go deeper? This course covers this topic with structured learning objectives and CEU credit.

Telehealth versus In Person Discrete Trial Teaching | Learning | 0.5 Hours — Autism Partnership Foundation · 0.5 BACB General CEUs · $0

Take This Course →
📚 Browse All 60+ Free CEUs — ethics, supervision & clinical topics in The ABA Clubhouse

Related Topics

CEU Course: Telehealth versus In Person Discrete Trial Teaching | Learning | 0.5 Hours

0.5 BACB General CEUs · $0 · Autism Partnership Foundation

Guide: Telehealth versus In Person Discrete Trial Teaching | Learning | 0.5 Hours — What Every BCBA Needs to Know

Research-backed educational guide with practice recommendations

Decision Guide: Comparing Approaches

Side-by-side comparison with clinical decision framework

Clinical Disclaimer

All behavior-analytic intervention is individualized. The information on this page is for educational purposes and does not constitute clinical advice. Treatment decisions should be informed by the best available published research, individualized assessment, and obtained with the informed consent of the client or their legal guardian. Behavior analysts are responsible for practicing within the boundaries of their competence and adhering to the BACB Ethics Code for Behavior Analysts.

60+ Free CEUs — ethics, supervision & clinical topics